Drug
Testim
Testim is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_4
2
67%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 42 (66.7%)
Trials by Status
terminated133%
unknown133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT04456296
terminatedearly_phase_1
Testosterone for Penile Rehabilitation After Radical Prostatectomy
NCT00848497
unknownphase_4
Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
NCT00700024
Clinical Trials (3)
Showing 3 of 3 trials
NCT04456296Phase 4
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
NCT00848497Early Phase 1
Testosterone for Penile Rehabilitation After Radical Prostatectomy
NCT00700024Phase 4
Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3